Food and Drug Administration

Transmissible Spongiform Encephalopathy Advisory Committee

February 20, 2003

Briefing Information

Issue Summary for Topic #1, "Consideration of Labeling Claims for Transmissible Spongiform Encephalopathy (TSE) Agent Clearance in Plasma Derivaties" (HTM) (PDF) (Word)

Bibliography (HTM) (PDF) (Word)